English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
The PTM profiling of CTCF reveals the regulation of 3D chromatin structure by O-GlcNAcylation Journal article
Tang, Xiuxiao, Zeng, Pengguihang, Liu, Kezhi, Qing, Li, Sun, Yifei, Liu, Xinyi, Lu, Lizi, Wei, Chao, Wang, Jia, Jiang, Shaoshuai, Sun, Jun, Chang, Wakam, Yu, Haopeng, Chen, Hebing, Zhou, Jiaguo, Xu, Chengfang, Fan, Lili, Miao, Yi Liang, Ding, Junjun. The PTM profiling of CTCF reveals the regulation of 3D chromatin structure by O-GlcNAcylation[J]. Nature Communications, 2024, 15(1), 2813.
Authors:  Tang, Xiuxiao;  Zeng, Pengguihang;  Liu, Kezhi;  Qing, Li;  Sun, Yifei; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:14.7/16.1 | Submit date：2024/05/16
Ccctc-binding-factor  Differential Expression  Phosphorylation Sites  Nuclear Factor  Genome  Gene  Pluripotency  Domains  Dna  Identification  
Lusianthridin ameliorates high fat diet-induced metabolic dysfunction-associated fatty liver disease via activation of FXR signaling pathway. Journal article
Tang, Xiaowen, Liao, Qi, Li, Qinqin, Jiang, Linshan, Li, Wei, Xu, Jie, Xiong, Aizhen, Wang, Rufeng, Zhao, Jing, Wang, Zhengtao, Ding, Lili, Yang, Li. Lusianthridin ameliorates high fat diet-induced metabolic dysfunction-associated fatty liver disease via activation of FXR signaling pathway.[J]. European Journal of Pharmacology, 2024, 965, 176196.
Authors:  Tang, Xiaowen;  Liao, Qi;  Li, Qinqin;  Jiang, Linshan;  Li, Wei; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.2/4.3 | Submit date：2024/02/22
Fxr  Lusianthridin  Mafld  Srebp1c  
Constructing virus-like SiO: X /CeO2/VOx nanozymes for 1064 nm light-triggered mild-temperature photothermal therapy and nanozyme catalytic therapy Journal article
Zhao, Ruoxi, Zhang, Rui, Feng, Lili, Dong, Yushan, Zhou, Jialing, Qu, Songnan, Gai, Shili, Yang, Dan, Ding, He, Yang, Piaoping. Constructing virus-like SiO: X /CeO2/VOx nanozymes for 1064 nm light-triggered mild-temperature photothermal therapy and nanozyme catalytic therapy[J]. Nanoscale, 2022, 14(2), 361-372.
Authors:  Zhao, Ruoxi;  Zhang, Rui;  Feng, Lili;  Dong, Yushan;  Zhou, Jialing; et al.
Favorite | TC[WOS]:23 TC[Scopus]:23  IF:5.8/6.1 | Submit date：2022/05/17